Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Mar 20, 2023

BUY
$53.86 - $66.52 $15,942 - $19,689
296 New
296 $16 Million
Q1 2022

Mar 21, 2023

BUY
$62.86 - $69.24 $17,223 - $18,971
274 New
274 $17.6 Million
Q4 2021

Mar 21, 2023

BUY
$62.47 - $73.25 $15,117 - $17,726
242 New
242 $16.2 Million
Q3 2021

Mar 22, 2023

BUY
$64.97 - $76.19 $20,400 - $23,923
314 New
314 $21.5 Million
Q2 2021

Mar 22, 2023

BUY
$66.79 - $76.63 $17,766 - $20,383
266 New
266 $18.2 Million
Q1 2021

Mar 22, 2023

BUY
$62.63 - $71.15 $14,342 - $16,293
229 New
229 $15.8 Million
Q4 2020

Mar 22, 2023

BUY
$43.31 - $66.55 $6,409 - $9,849
148 New
148 $9.61 Million
Q3 2020

Mar 22, 2023

BUY
$43.33 - $51.72 $9,532 - $11,378
220 New
220 $10.4 Million
Q2 2020

Mar 24, 2023

SELL
$41.42 - $55.57 $16,816 - $22,561
-406 Reduced 68.58%
186 $8.74 Million
Q1 2020

Mar 24, 2023

BUY
$36.67 - $61.04 $21,708 - $36,135
592 New
592 $26.4 Million
Q4 2019

Mar 24, 2023

BUY
$55.73 - $62.49 $30,762 - $34,494
552 New
552 $32.2 Million
Q3 2019

Mar 24, 2023

BUY
$53.29 - $64.59 $24,140 - $29,259
453 Added 520.69%
540 $32.4 Million
Q2 2019

Mar 24, 2023

BUY
$46.45 - $55.85 $4,041 - $4,858
87 New
87 $4.86 Million
Q1 2019

Mar 24, 2023

BUY
$42.97 - $57.33 $2,234 - $2,981
52 Added 226.09%
75 $4.18 Million
Q4 2018

Mar 24, 2023

SELL
$42.62 - $64.51 $724 - $1,096
-17 Reduced 42.5%
23 $1.04 Million
Q3 2018

Mar 24, 2023

BUY
$57.63 - $65.87 $2,305 - $2,634
40 New
40 $2.64 Million
Q1 2018

Mar 24, 2023

BUY
$46.55 - $57.38 $1,536 - $1,893
33 New
33 $1.83 Million
Q4 2017

Mar 24, 2023

BUY
$46.22 - $51.77 $1,525 - $1,708
33
33 $1.58 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $2.2B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.